SRPTSarepta TherapeuticsHealth Care
$17.87EarningsAug 5, 2026
1D—1W—1M—3M—1Y—
Market cap$2.2BCompany infoRevenue$2.2B52-wk range$12 – $24IndustryBiotechnologyWebsitesarepta.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −5.8% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E———
P / S1.0×8280
1
12
P / FCF20.3×4746
EV / EBITDA18.9×3135
23
132
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin62.4%7356
62%
88%
Operating margin-1.9%611
-105%
11%
Net margin3.0%2131
-114%
12%
ROE5.0%2032
-179%
21%
ROIC-1.7%612
-31%
7%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.565652
0.6
4.0
Net debt / EBITDA1.5×4948
Current ratio4.639288
Interest coverage-1.0×611
Per shareTTM, with year-over-year change
Revenue / share$17.92▼ −2%
EPS (diluted)$-0.96▲ +64%
FCF / share$0.88▲ +115%
Est. EPS growth (fwd)—